Teva Pharmaceutical Industries (TEVA) Free Cash Flow Growth (1y) (2010 - 2026)
Teva Pharmaceutical Industries (TEVA) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | 44.93% |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | 124.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.34% |
| Dec 31, 2025 | 127.80% |
| Sep 30, 2025 | -57.25% |
| Jun 30, 2025 | 2,083.33% |
| Mar 31, 2025 | 6.45% |
| Dec 31, 2024 | -58.12% |
| Sep 30, 2024 | 478.47% |
| Jun 30, 2024 | -97.07% |
| Mar 31, 2024 | 12.68% |
| Dec 31, 2023 | 28.16% |
| Sep 30, 2023 | -134.20% |
| Jun 30, 2023 | 5,225.00% |
| Mar 31, 2023 | -37.86% |
| Dec 31, 2022 | 174.26% |
| Sep 30, 2022 | 9.92% |
| Jun 30, 2022 | -103.81% |
| Mar 31, 2022 | 62.88% |
| Dec 31, 2021 | 95.48% |
| Sep 30, 2021 | 133.54% |
| Jun 30, 2021 | -26.06% |